Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health

Core Viewpoint - Elite Pharmaceuticals has received marketing approval from the Israeli Ministry of Health for its generic version of Adderall®, which is indicated for the treatment of ADHD and Narcolepsy [2][3]. Company Overview - Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing niche generic products, including immediate-release and controlled-release solid oral dose products [4]. - The company operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ [4]. Product Details - The approved generic Adderall® comes in strengths of 10 mg, 20 mg, and 30 mg tablets and is a central nervous system stimulant [2]. - The product will be supplied to Dexcel Pharma, the exclusive distributor for the Israeli market, under a License and Distribution Agreement [3]. Distribution Agreement - Under the agreement, Elite will manufacture and package the product, while Dexcel will handle sales, marketing, and distribution at its own expense [3]. - Dexcel will pay an agreed transfer price for the product and share profits under certain conditions [3].